Stock BLRX BIOLINERX LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart BioLineRx Ltd.

Equities

BLRX

IL0011015182

Market Closed - TEL AVIV STOCK EXCHANGE
Other stock markets
 10:24:53 2024-05-28 am EDT 		5-day change 1st Jan Change
17.7 ILa +2.91% Intraday chart for BioLineRx Ltd. +11.32% -53.66%
02:30pm Transcript : BioLineRx Ltd., Q1 2024 Earnings Call, May 28, 2024
May. 24 BioLineRx Ltd. Announces Abstract on Pilot Study Data from Phase 2 Combination Clinical Trial Evaluating Motixafortide in First-Line Pancreatic Cancer at American Society of Clinical Oncology CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
BIOLINERX LTD. Stock BioLineRx Ltd.
 56.09M - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 118B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 106B
BIONTECH SE Stock BioNTech SE
 23.4B -
ARGENX SE Stock argenx SE
 22.1B -
GENMAB A/S Stock Genmab A/S
 18.34B
  1. Stock Market
  2. Equities
  3. BLRX Stock
  4. Charts BioLineRx Ltd.
  5. Sector Chart